12,290
Views
1
CrossRef citations to date
0
Altmetric
Introduction

Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue

ORCID Icon &

References

  • Adelson, M., Linzy, S., & Peles, E. (2018). Characteristics and outcome of male and female methadone maintenance patients: MMT in Tel Aviv and Las Vegas. Substance Use and Misuse, forthcoming.
  • Ahmadi, J., & Jahromi, M. S. (2018). Ultra-rapid influence of buprenorphine on depression in opioid dependent patients: A double blind, randomized clinical trial. Substance Use and Misuse, forthcoming.
  • Ali, N., Abd Aziz, S., Nordin, S., Che Mi, N., Abdullah, N., Paranthaman, V., Mahmud, M., Yee, A., & Danaee, M. (2018). Evaluation of methadone treatment in Malaysia – Findings from the Malaysian Methadone Treatment Outcome study (MyTOS). Substance Use and Misuse, forthcoming.
  • Blum, K., Han, D., Modestino, E., Saunders, S., Roy, A. K., Jacobs, W., Inaba, D., Badgaiyan, R., Baron, D., Oscar-Berman, M., Hauser, M., & Gold, M. (2018). Compliance and abstinence with buprenorphine/naloxone treatment for opioid dependence. Substance Use and Misuse, forthcoming.
  • Frank, D. (2018). “I was not sick and I didn't need to recover”: Methadone Maintenance Treatment (MMT) as a refuge from criminalization. Substance Use and Misuse, forthcoming.
  • Global Commission on Drug Policy (2017). The opioid crisis in North America. Geneva: Global Commission on Drug Policy. Retrieved from http://www.globalcommissionondrugs.org/wp-content/uploads/2017/09/2017-GCDP-Position-Paper-Opioid-Crisis-ENG.pdf
  • Hatcher, A., Mendoza, S., & Hansen, H. (2018). At the expense of a life: Race, class, and the meanings of buprenorphine in pharmaceuticalized “care”. Substance Use and Misuse, forthcoming.
  • Joseph, H., & Woods, J. S. (2018). Changing the treatment direction for opiate addiction: Dr. Dole's research. Substance Use and Misuse, forthcoming.
  • Khan, F., Krishnan, A., Ghani, M. A., Wickersham, J. A., Fu, J. J., Lim, S. H., Dhaliwal, S. K., Kamarulzaman, A., & Altice, F. L. (2018). Assessment of an innovative voluntary substance abuse treatment program designed to replace compulsory drug detention centers in Malaysia. Substance Use and Misuse, forthcoming.
  • King, N. B., Fraser, V., Boikos, C., Richardson, R., & Harper, S. (2014). Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990–2013: A Systematic Review. American Journal of Public Health, 104(8), e32–e42.
  • Klimas, J., Wood, E., Nosova, E., Milloy, M. J., Kerr, T., & Hayashi, K. (2018). Prevalence of heavy alcohol use among people receiving methadone following change to Methadose. Substance Use and Misuse, forthcoming.
  • Kovitwanichkanont, T., & Day, C. (2018). Prescription opioid misuse and public health approach in Australia. Substance Use and Misuse, forthcoming.
  • Lin, C., Tuan, N. A., & Li, L. (2018). Commune health workers’ MMT knowledge and perceived difficulties providing decentralized MMT services in Vietnam. Substance Use and Misuse, forthcoming.
  • Livingston, J., Adams, E., Jordan, M., MacMillan, Z., & Hering, R. (2018). Primary care physicians’ views about prescribing methadone to treat opioid use disorder. Substance Use and Misuse, forthcoming.
  • Matusow, H., Benoit, E., Elliott, L., Dunlap, E., & Rosenblum, A. (2018). Challenges to opioid treatment programs after Hurricane Sandy: Patient and provider perspectives on preparation, impact, and recovery. Substance Use and Misuse, forthcoming.
  • McElrath, K. (2018). Medication-assisted treatment for opioid dependency in the United States: Critique and commentary. Substance Use and Misuse, forthcoming.
  • Parrino, M. W. (2018). Overcoming impediments to OTP expansion in the US and abroad. Substance Use and Misuse, forthcoming.
  • Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., Bruneau, J., & Hickman, M. (2017). Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database of Systematic Reviews, 9: CD012021. doi:10.1002/14651858.CD012021.pub2.
  • Pouget, E., Fong, C., & Rosenblum, A. (2018). Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, Substance Use and Misuse, forthcoming, 2005–2016.
  • Roy, E., Arruda, N., & Bourgois, P. (2011). The growing popularity of prescription opioid injection in downtown Montreal: New challenges for harm reduction. Substance Use and Misuse, 46, 1142–1150.
  • Shrestha, S., Jimenez, E., Garrison, L., Pribis, P., Raisch, D., Stephen, J. M., & Bakhireva, L. N. (2018). Dietary intake among opioid dependent and alcohol using pregnant women. Substance Use and Misuse, forthcoming.
  • United Nations Office on Drugs and Crime. (2017). Global overview of drug demand and supply: Latest trends, cross-cutting issues. In World Drug Report, 2017 (part 2). Vienna: United Nations Office on Drugs and Crime. Retrieved from http://www.unodc.org/wdr2017/field/Booklet_2_HEALTH.pdf
  • Vilibic-Cavlek, T., Kucinar, J., Kaic, B., Vilibic, M., Pandak, N., Barbic, L., Stevanovic, V., & Vranes, J. (2015). Epidemiology of hepatitis C in Croatia in the European context. World Journal of Gastroenterology, 21(32), 9476–9493.
  • Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use and Misuse, forthcoming.
  • Woods, J. S., & Joseph, H. (2018). From narcotic to normalizer: The misperception of methadone treatment and the persistence of prejudice and bias. Substance Use and Misuse, forthcoming.
  • Yee, A., Hoong, M. C., Joyce, Y. C., & Loh, H. S. (2018). Smoking cessation among methadone-maintained patients: A meta-analysis. Substance Use and Misuse, forthcoming.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.